Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 2;7(18):628-634.
doi: 10.46234/ccdcw2025.104.

Impact of Implementation Interruptions of 1,7-Malaria Reactive Community-Based Testing and Response Approach on Malaria Control Efforts - Southern Tanzania

Affiliations

Impact of Implementation Interruptions of 1,7-Malaria Reactive Community-Based Testing and Response Approach on Malaria Control Efforts - Southern Tanzania

Yuejin Li et al. China CDC Wkly. .

Abstract

Introduction: Surveys from the China-Tanzania Malaria Control Project demonstrated that the 1,7-malaria Reactive Community-Based Testing and Response (1,7-mRCTR) approach significantly reduced malaria incidence rates. However, implementation was disrupted by security concerns, infectious disease outbreaks, and supply shortages. This study evaluates how these interruptions affected intervention effectiveness to inform future malaria control strategies.

Methods: The study employed a two-phased design: Phase I (2016-2018) and Phase II (2019-2021). Weekly malaria incidence rates per 100 people were calculated from cases reported by local health facilities in the intervention areas during both phases. Seasonal and trend decomposition using loess (STL) and interrupted time series modeling with piecewise linear regression were used to evaluate the impact of disruptions on 1,7-mRCTR implementation effectiveness.

Results: In Tanzania's 1,7-mRCTR areas, malaria incidence peaked during November-December and June-July. Phase I's 8-month interruption reversed the weekly trend from a 0.17% decline to a 0.58% increase (P=0.001). After resumption, incidence dropped 8.96% (P=0.039) and maintained a 0.39% long-term decline (P=0.003). Even with seasonal adjustment, the interruption slowed the weekly decline from 0.08% to 0.07% (P=0.003). Phase II showed a similar pattern: a one-week interruption caused a 0.70% drop (P=0.007) but shifted the trend from a 0.02% decline to a 0.08% increase (P=0.001). After resumption, interventions stabilized the decline at 0.11% weekly (P=0.001).

Conclusions: This research demonstrates that Tanzania's malaria incidence is closely linked to seasonal patterns and consistent intervention efforts. Phase I's 8-month security-related interruption reduced 1,7-mRCTR effectiveness by 12.5%, while Phase II's 3-month pandemic-induced interruption caused only short-term fluctuations with minimal long-term impact. Rapid resumption of interventions after disruptions allowed for prompt recovery, highlighting the importance of adaptive strategies to maintain progress toward malaria control goals.

Keywords: 1; 7-mRCTR; Implementation; Interrupted time series analysis; Malaria; Surveillance and response.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest.

Figures

Figure 1
Figure 1
Weekly incidence changes of malaria in 1,7-malaria Reactive Community-Based Testing and Response intervention and control areas in Tanzania. (A) Phase I; (B) Phase II.
Figure 2
Figure 2
Time series decomposition plot of malaria incidence in 1,7-malaria Reactive Community-Based Testing and Response implementation areas. (A) Phase I; (B) Phase II.
Figure 3
Figure 3
ITS scatter plot of the weekly malaria incidence in Phase I implementation areas, Tanzania. (A) Implementation interrupted; (B) Implementation interrupted after removing seasonality.
Figure 4
Figure 4
ITS scatter plot of the weekly malaria incidence in Phase II implementation areas, Tanzania. (A) Implementation interrupted; (B) Implementation interrupted after removing seasonality.

Similar articles

References

    1. Poespoprodjo JR, Douglas NM, Ansong D, Kho S, Anstey NM Malaria. Lancet. 2023;402(10419):2328–45. doi: 10.1016/S0140-6736(23)01249-7. - DOI - PubMed
    1. World Health Organization. World malaria report 2023. Geneva: World Health Organization; 2023. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023.[2023-11-30].

    1. Ochomo E, Rund SSC, Mthawanji RS, Antonio-Nkondjio C, Machani M, Samake S, et al Mosquito control by abatement programmes in the United States: perspectives and lessons for countries in sub-Saharan Africa. Malar J. 2024;23(1):8. doi: 10.1186/s12936-023-04829-3. - DOI - PMC - PubMed
    1. Muthoka EN, Usmael K, Embaye SM, Abebe A, Mesfin T, Kazembe D, et al Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials. Malar J. 2023;22(1):320. doi: 10.1186/s12936-023-04757-2. - DOI - PMC - PubMed
    1. Ma XJ, Lu SN, Wang DQ, Zhou ZB, Feng J, Yan H, et al China-UK-Tanzania pilot project on malaria control. China CDC Wkly. 2020;2(42):820–2. doi: 10.46234/ccdcw2020.179. - DOI - PMC - PubMed

LinkOut - more resources